{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:03:53Z","timestamp":1787504633115,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.medcli.2025.106920","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:12:35Z","timestamp":1744348355000},"page":"106920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness and immunogenicity of SARS-CoV-2 booster vaccine in immunosuppressed systemic autoimmune disease patients: A prospective study"],"prefix":"10.1016","volume":"164","author":[{"given":"Carolina","family":"Teles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1tia","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e8lita","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2025.106920_bib0250","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/biomedicines10040834","article-title":"Immunogenicity effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis","volume":"10","author":"Tang","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.medcli.2025.106920_bib0255","first-page":"1","article-title":"Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis","volume":"19","author":"Mehrabi","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.medcli.2025.106920_bib0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijid.2022.10.035","article-title":"Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: a prospective multicenter longitudinal study","volume":"125","author":"Farroni","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0265","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","article-title":"Covid-19 vaccines\u2014immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2025.106920_bib0270","doi-asserted-by":"crossref","first-page":"SI180","DOI":"10.1093\/rheumatology\/keac089","article-title":"Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions","volume":"61","author":"Krasselt","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.medcli.2025.106920_bib0275","doi-asserted-by":"crossref","first-page":"102927","DOI":"10.1016\/j.autrev.2021.102927","article-title":"Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis","volume":"21","author":"Jena","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2025.106920_bib0280","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1002\/jmv.27954","article-title":"Antibody titers after a third dose of the SARS-CoV-2 BNT162b2 vaccine in immunocompromised adults in Greece: is a fourth dose necessary?","volume":"94","author":"Kontopoulou","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.medcli.2025.106920_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.02.002","article-title":"The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients","volume":"28","author":"Saiag","year":"2022","journal-title":"Clin Microbial Infect"},{"key":"10.1016\/j.medcli.2025.106920_bib0290","doi-asserted-by":"crossref","first-page":"100164","DOI":"10.1016\/j.jtauto.2022.100164","article-title":"COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies","volume":"5","author":"Gragnani","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.medcli.2025.106920_bib0295","first-page":"10","article-title":"Booster COVID-19 vaccines for immune-mediated inflammatory disease patients: a systematic review and meta-analysis of efficacy and safety","author":"Lee","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.medcli.2025.106920_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-022-00247-1","article-title":"Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases","volume":"43","author":"Kato","year":"2023","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.medcli.2025.106920_bib0305","doi-asserted-by":"crossref","first-page":"102243","DOI":"10.1016\/j.coph.2022.102243","article-title":"Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases","volume":"65","author":"Paik","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.medcli.2025.106920_bib0310","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1093\/rheumatology\/keac209","article-title":"Autoimmune disease and COVID-19: a multicentre observational study in the United Kingdom","volume":"61","author":"Arachchillage","year":"2022","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.medcli.2025.106920_bib0315","article-title":"Severe COVID-19 in patients with immune-mediated rheumatic diseases: a stratified analysis from the SORCOM multicentre registry","author":"Boteanu","year":"2022","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.medcli.2025.106920_bib0320","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s10067-022-06087-1","article-title":"Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis","volume":"41","author":"Wang","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.medcli.2025.106920_bib0325","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00011-021-01446-1","article-title":"COVID-19 illness and autoimmune diseases: recent insights","volume":"70","author":"Li","year":"2021","journal-title":"Inflamm Res"},{"key":"10.1016\/j.medcli.2025.106920_bib0330","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/annrheumdis-2021-222096","article-title":"Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases","author":"Aikawa","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0335","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2021-221575","article-title":"Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations","volume":"81","author":"Kroon","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0340","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/annrheumdis-2021-221824","article-title":"BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study","volume":"81","author":"Bieber","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0345","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1093\/rheumatology\/keac296","article-title":"COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases","volume":"61","author":"Cardelli","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2025.106920_bib0350","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/annrheumdis-2021-222006","article-title":"EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update","author":"Landew\u00e9","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0355","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/art.42372","article-title":"American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5","volume":"75","author":"Curtis","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2025.106920_bib0360","unstructured":"Dire\u00e7\u00e3o-Geral de Sa\u00fade. Norma 002\/2021 \u2013 Vacina\u00e7\u00e3o Contra a COVID-19; 2022. https:\/\/www.dgs.pt\/normas-orientacoes-e-informacoes\/normas-e-circulares-normativas\/norma-n-0022021-de-30012021-pdf.aspx [accessed 2.3.23]."},{"key":"10.1016\/j.medcli.2025.106920_bib0365","doi-asserted-by":"crossref","first-page":"100587","DOI":"10.1016\/j.esmoop.2022.100587","article-title":"Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment","volume":"7","author":"Su","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.medcli.2025.106920_bib0370","series-title":"Living guidance for clinical management of COVID-19, 23 November 2021. Report","year":"2021"},{"key":"10.1016\/j.medcli.2025.106920_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2022.901817","article-title":"Risk factors for infection, predictors of severe disease, and antibody response to COVID-19 in patients with inflammatory rheumatic diseases in Portugal\u2014a multicenter, nationwide study","volume":"9","author":"Cruz-Machado","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.medcli.2025.106920_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v14122605","article-title":"Antibody titer correlates with omicron infection in vaccinated healthcare workers","volume":"14","author":"Mollura","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.medcli.2025.106920_bib0385","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard-2022-222689","article-title":"SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort study","volume":"81","author":"Kim","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0390","doi-asserted-by":"crossref","first-page":"102866","DOI":"10.1016\/j.jaut.2022.102866","article-title":"Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases","volume":"131","author":"Ferri","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.medcli.2025.106920_bib0395","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/rmdopen-2022-002279","article-title":"Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases","volume":"8","author":"Fragoulis","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.medcli.2025.106920_bib0400","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/ard-2022-222682","article-title":"Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls","volume":"82","author":"Kartnig","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0405","doi-asserted-by":"crossref","first-page":"102981","DOI":"10.1016\/j.jaut.2022.102981","article-title":"Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases","volume":"135","author":"Mrak","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.medcli.2025.106920_bib0410","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-022-00801-8","article-title":"A single dose of COVID-19 vaccine induces a strong T cell and B cell response in healthcare professionals recovered from SARS-CoV-2 infection","author":"Laranjeira","year":"2022","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.medcli.2025.106920_bib0415","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2021-220626","article-title":"Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression","volume":"80","author":"Prendecki","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0266852","article-title":"Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review","volume":"17","author":"Perry","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.medcli.2025.106920_bib0425","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2025.106920_bib0430","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/annrheumdis-2021-221922","article-title":"Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort","volume":"81","author":"Ahmed","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0435","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1002\/jmv.28063","article-title":"The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNF\u03b1 blockade","volume":"94","author":"Geisen","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.medcli.2025.106920_bib0440","doi-asserted-by":"crossref","first-page":"102743","DOI":"10.1016\/j.jaut.2021.102743","article-title":"A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases","volume":"125","author":"Tzioufas","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.medcli.2025.106920_bib0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciab407","article-title":"Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) pandemic in people with autoimmune diseases","volume":"74","author":"Fitzgerald","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2023.01.006","article-title":"Recognizing risk factors associated with poor outcomes among patients with COVID-19","volume":"76","author":"Rodriguez-Miguelez","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0455","doi-asserted-by":"crossref","first-page":"101505","DOI":"10.1016\/j.genrep.2022.101505","article-title":"Global data analysis and risk factors associated with morbidity and mortality of COVID-19","volume":"26","author":"Salajegheh","year":"2022","journal-title":"Gene Rep"},{"key":"10.1016\/j.medcli.2025.106920_bib0460","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3961\/jpmph.21.640","article-title":"Vitamin D deficiency and comorbidities as risk factors of COVID-19 infection: a systematic review and meta-analysis","volume":"55","author":"Mishra","year":"2022","journal-title":"J Prev Med Public Heal"},{"key":"10.1016\/j.medcli.2025.106920_bib0465","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","article-title":"Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients","volume":"21","author":"Dessie","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2021.588013","article-title":"Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis","volume":"8","author":"Geng","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.medcli.2025.106920_bib0475","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.21037\/jtd-20-1743","article-title":"Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression","volume":"12","author":"Zhang","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.medcli.2025.106920_bib0480","first-page":"36","article-title":"Risk factors for SARS-CoV-2 infection in patients with rheumatic diseases","volume":"131","author":"Snarska","year":"2021","journal-title":"Polish Arch Intern Med"},{"key":"10.1016\/j.medcli.2025.106920_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-02017-8","article-title":"Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study","volume":"21","author":"Simon","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.medcli.2025.106920_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5888\/pcd19.210228","article-title":"COVID-19 severity and mortality among chronic liver disease patients: a systematic review and meta-analysis","volume":"19","author":"Nagarajan","year":"2022","journal-title":"Prev Chronic Dis"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T13:40:10Z","timestamp":1750426810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775325001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0025775325001149"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2025.106920","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and immunogenicity of SARS-CoV-2 booster vaccine in immunosuppressed systemic autoimmune disease patients: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2025.106920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106920"}}